A company offering experimental stem-cell treatments will carry out its procedures in Mexico after the FDA warned that it would need approval to operate in the U.S.
Advertisement
The Scientist
Most Recent
Patient safety is paramount in regulating new stem cell treatments.
Two former Geron CEOs make a bid for the company’s defunct human embryonic stem cell business.
In a Phase I trial, researchers show that neural stem cells transplanted into humans can differentiate and begin producing myelin.
Japanese researchers are launching an iPS cell trial for an untreatable eye disease, challenging ongoing embryonic stem cell trials.
Page 1 of 1
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
